November 24, 2023

Digital WuXi Global Forum 2024

Date and time

January 31, 2024 ~ January 31, 2024

7:00 AM-11:30 AM PST and 7:00 PM-11:30 PM PST

Dear Colleagues and Friends,

Following the resounding success of the 12^th annual WuXi Global Forum during JPM2024, we're bringing the experience online for colleagues around the world unable to attend in person. Join us for the Digital WuXi Global Forum 2024 on Jan 31, to be premiered at 7:00-11:30 AM and 7:00-11:30 PM PST respectively.

This year's theme, B.O.L.D., focuses on Breaking Barriers, Opening New Horizons, Leading Next Generation, and Delivering for Patients. We will delve deep into what matters most to patients.

Thank you to our distinguished speakers, supportive partners, and thousands of attendees who made our in-person Forum a success.

Agenda

07:00 AM - 07:05 AM Welcome and Opening Remarks
Hui Cai, Program Chair and Vice President, WuXi AppTec
Minzhang Chen, Co-CEO, WuXi AppTec
07:05 AM - 07:50 AM State of Innovation 2024
Amy Abernethy, CMO & President, Product Development, Verily
Donald Ingber, Founding Director & Chaired Professor, Wyss Institute at Harvard University
Mathai Mammen, CEO & Chairman, FogPharma
John Maraganore, CEO, JMM Innovations
Søren Møller, Managing Partner, Seed Investments, Novo Holdings
Session Leader: Christoph Westphal, Co-Founder & General Partner, Longwood Fund

Spotlight on B.O.L.D.
07:50 AM - 08:25 AM Breaking Barriers. Leaping Forward.
Robert Gabbay, CSO & CMO, American Diabetes Association
Karen Knudsen, CEO, American Cancer Society and ACS CAN; Professor, Sidney Kimmel Cancer Center at Jefferson Health
Joseph Wu, President, American Heart Association; Director, Stanford Cardiovascular Institute; Co-Founder, Greenstone Biosciences
Session Leader: Margo Georgiadis, Co-Founder & CEO, Montai Health; CEO-Partner, Flagship Pioneering
08:25 AM - 09:10 AM Opening Up New Horizons: Spotlight on Cancer
Philip Kantoff, Co-Founder & CEO, Convergent Therapeutics
Samir Khleif, Founder & CEO, Georgiamune
Crystal Mackall, Professor of Pediatrics and Medicine, Stanford University; Director, Stanford Center for Cancer Cell Therapy
Briggs Morrison, CEO, Crossbow Therapeutics
Session Leader: Karen Tkach Tuzman, Director, Biopharma Intelligence, BioCentury
09:10 AM - 09:55 AM Leading Transformation: The Next Wave Therapeutics
Wolfram Carius, EVP Pharmaceuticals, Bayer
Abraham Ceesay, CEO, Rapport Therapeutics
Pavan Cheruvu, President & CEO, Bitterroot Bio
Giuseppe “Pino” Ciaramella, Co-Founder & CEO, Orbital Therapeutics; President, Beam Therapeutics
Kevin Forrest, Co-Founder, President & CEO, Kate Therapeutics
Amber Salzman, CEO, Epic Bio
Session Leader: Edward Hu, Vice Chairman, WuXi AppTec; CEO, WuXi Advanced Therapies
09:55 AM - 10:40 AM Delivering on Future Platform Solutions
Miles Congreve, CSO, Isomorphic Labs
Evan Feinberg, Co-Founder & CEO, Genesis Therapeutics
Nevan Krogan, Co-Founder & President, Rezo Therapeutics; Professor, Cellular and Molecular Pharmacology, UCSF; Investigator, J. David Gladstone Institutes
Ann Lee-Karlon, President & CEO, EpiBiologics
Sabrina Yang, Co-Founder & CIO, Empress Therapeutics; Principal, Flagship Pioneering
Session Leader: John Carroll, Editor & Founder, Endpoints News
10:40 AM - 11:30 AM Scaling Breakthroughs Forward
Vineeta Agarwala, General Partner, Andreessen Horowitz (a16z) Bio + Health
Alexis Borisy, Co-Founder & Chairman, Curie.Bio
Laura Furmanski, Partner, Patient Square Capital
Rogier Rooswinkel, General Partner, Forbion
Tim Shannon, General Partner, Canaan
John Wesley, Investment Director, NVentures
Session Leader: Steve Yang, Co-CEO, WuXi AppTec

Speakers

Amy Abernethy
CMO & President, Product Development, Verily
Vineeta Agarwala
General Partner, Andreessen Horowitz (a16z) Bio + Health
Alexis Borisy
Co-Founder & Chairman, Curie.Bio
Wolfram Carius
EVP Pharmaceuticals, Bayer
John Carroll
Editor & Founder, Endpoints News
Abraham Ceesay
CEO, Rapport Therapeutics
Pavan Cheruvu
President & CEO, Bitterroot Bio
Giuseppe "Pino" Ciaramella
Co-Founder & CEO, Orbital Therapeutics; President, Beam Therapeutics
Miles Congreve
CSO, Isomorphic Labs
Evan Feinberg
Co-Founder & CEO, Genesis Therapeutics
Kevin Forrest
Co-Founder, President & CEO, Kate Therapeutics
Laura Furmanski
Partner, Patient Square Capital
Robert Gabbay
CSO & CMO, American Diabetes Association
Margo Georgiadis
Co-Founder & CEO, Montai Health; CEO-Partner, Flagship Pioneering
Donald Ingber
Founding Director & Chaired Professor, Wyss Institute at Harvard University
Philip Kantoff
Co-Founder & CEO, Convergent Therapeutics
Samir Khleif
Founder & CEO, Georgiamune
Karen Knudsen
CEO, American Cancer Society and ACS CAN; Professor, Sidney Kimmel Cancer Center at Jefferson Health
Nevan Krogan
Co-Founder & President, Rezo Therapeutics; Professor, Cellular and Molecular Pharmacology, UCSF; Investigator, J. David Gladstone Institutes
Ann Lee-Karlon
President & CEO, EpiBiologics
Crystal Mackall
Professor of Pediatrics and Medicine, Stanford University; Director, Stanford Center for Cancer Cell Therapy
Mathai Mammen
CEO & Chairman, FogPharma
John Maraganore
CEO, JMM Innovations
Søren Møller
Managing Partner, Seed Investments, Novo Holdings
Briggs Morrison
CEO, Crossbow Therapeutics
Rogier Rooswinkel
General Partner, Forbion
Amber Salzman
CEO, Epic Bio
Tim Shannon
General Partner, Canaan
Karen Tkach Tuzman
Director, Biopharma Intelligence, BioCentury
John Wesley
Investment Director, NVentures
Christoph Westphal
Co-Founder & General Partner, Longwood Fund
Joseph Wu
President, American Heart Association; Director, Stanford Cardiovascular Institute; Co-Founder, Greenstone Biosciences
Sabrina Yang
Co-Founder & CIO, Empress Therapeutics; Principal, Flagship Pioneering
Edward Hu
Vice Chairman, WuXi AppTec; CEO, WuXi Advanced Therapies – host
Minzhang Chen
Co-CEO, WuXi AppTec – host
Steve Yang
Co-CEO, WuXi AppTec – host
Hui Cai
Program Chair and Vice President, WuXi AppTec – host